Last reviewed · How we verify
NCT06011564
eDENT Oral Health- the Gateway to Quality of Care and Everyday Life at Old Age
NA trial testing Reminder function on Android computer tablet in Mild Cognitive Impairment in 213 participants. Completed in 15 January 2023.
15 January 2023
Quick facts
| Lead sponsor | Blekinge Institute of Technology |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 213 |
| Start date | 1 June 2018 |
| Primary completion | 15 January 2023 |
| Estimated completion | 15 January 2023 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Reminder function on Android computer tablet
Conditions studied
- Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
- Gingivitis — all drugs for Gingivitis →
- Periodontal Diseases — all drugs for Periodontal Diseases →
Sponsor
Blekinge Institute of Technology
Who can join
55 and older, any sex, with Mild Cognitive Impairment or Gingivitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators will present a new strategy for working with oral health for the group of elderly people with various degrees of mild cognitive impairments. The investigators hope that by introducing a powered toothbrush with functions that make it possible to remind and gather information about the use, the investigators will primarily facilitate oral care for this group, and are proposing that this will lead to higher quality of life of the persons involved.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06011564
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mild Cognitive Impairment
Currently open trials in the same condition.
- NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
- NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting
Other Blekinge Institute of Technology trials
Trials by the same sponsor.
- NCT07201610 — Non-invasive Diagnosis of Parkinson's Disease · not yet recruiting
- NCT06705647 — Analyzing Acoustic Properties of the Vowel "a" Collected Via Mobile Phone From Individuals Diagnosed With Chronic Obstru · active not recruiting
- NCT06611475 — Prediction of MMSE Scores for Cognitive Impairment · completed
- NCT06160674 — Vowel Segmentation for Classification of Chronic Obstructive Pulmonary Disease Using Machine Learning · active not recruiting
- NCT05897944 — Creating and Assessing a Voice Dataset for Automated Classification of Chronic Obstructive Pulmonary Disease · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06011564 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Blekinge Institute of Technology
- Last refreshed: 25 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06011564.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing